Published: February 2, 2018

InSphero Joins Global Consortium Dedicated to Enhancing Safety Testing of Engineered Nanomaterials

InSphero Joins Global Consortium Dedicated to Enhancing Safety Testing of Engineered Nanomaterials

Nanosafety experts from more than 30 institutions convene in Swansea, Wales, for the PATROLS project kick-off meeting.

Schlieren, Switzerland - February 1, 2018 - InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, today announced that it is participating in a new €12.7m global project under the European Commission’s Horizon 2020 initiative and led by Swansea University that will address the need for safer and more effective testing of nanomaterials, an area that is of crucial and growing importance to billion-pound markets including cosmetics, electronics, medicine and food.

The Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS) project involves 24 partners, across Europe, the USA, and Asia with representatives from academia, industry, and Government. The project is coordinated by Shareen Doak, Professor of Genotoxicology & Cancer at Swansea University Medical School, UK, and over the next 3.5 years, the PATROLS scientists aim to establish a battery of innovative, next-generation safety testing tools that more accurately predict adverse effects caused by long-term ENM exposure in humans and the environment. PATROLS launched on January 1, 2018, and on January 29-30, the international consortium, which includes academic, industrial, government, and risk assessment partners involved in the project, attended a conference at the Waterfront Museum, Swansea, Wales, UK to discuss developments and plans.

The Nanotechnology industry promises significant scientific, economic, and societal benefits, but commercialization and growth are threatened by safety uncertainties. Exposure to some engineered nanomaterials (ENM) can pose a risk to human and environmental health. However, at present, the test methods used to assess this risk are inadequate and unrealistic. Current test systems utilize scientific models that lack the detail and complexity of the environment and the human body and only consider the effects of short-term ENM exposure, which does not reflect realistic extended or repeated exposure scenarios.

PATROLS aims to address current issues surrounding nanosafety testing by:

  • Producing realistic and predictive cultured 3D tissue models of the lung, gastrointestinal tract, and liver for ENM safety assessment
  • Developing innovative methods for safety assessment in ecologically relevant test systems and organisms, selected according to their position in the food chain.
  • Characterizing ENM under relevant experimental conditions dictated by the advanced human and environmental models developed.
  • Creating robust computational methods for ENM exposure, dose modeling, and hazard prediction.

Professor Doak said, “The cutting-edge models, hazard reporter tests, and computational methods developed through PATROLS will allow ENM to be categorized based on their human and environmental risk. The improved predictivity of the tools generated will help to minimize uncertainty in ENM safety. Furthermore, the PATROLS toolbox will provide effective data to support and enhance the current ENM safety evaluation.”

As a PATROLS partner, InSphero is using 3D InSight™ Human Liver Microtissues to test the toxic effects of engineered nanomaterials. This liver model has already been extensively validated for the assessment of drug-induced liver injury (DILI) caused by chemicals and pharmaceuticals. The work performed in the context of PATROLS will further validate the suitability of 3D InSight™ Human Liver Microtissues for liver-related risk assessment of ENMs, which possess a wide variety of different physical, chemical, and pharmacodynamic properties.

Dr. Wolfgang Moritz, InSphero Head of External Collaborations and IP, said, "PATROLS is an important project with great potential for improving safety testing. We are looking forward to working with the extraordinary team of scientists and nanosafety experts Professor Doak and her team have assembled."

To learn more about the PATROLS project, contact Kevin Fernquest, Project Manager – PATROLS Horizon2020.

Other News

Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

View resource

Fill in the form below to view this resource